{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:52:30Z","timestamp":1791100350003,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphoid leukemia (CLL) is characterized by the accumulation of functionally defective CD5-positive B lymphocytes. The clinical course of CLL is highly variable, ranging from a long-lasting indolent disease to an unpredictable and rapidly progressing leukemia requiring treatment. It is thus important to identify novel factors that reflect disease progression or contribute to its assessment. Here, we report on a novel STAT3-mediated pathway that characterizes CLL B cells-extended viability and oxidative stress control. We observed that leukemic but not normal B cells from CLL patients exhibit constitutive activation of an atypical form of the STAT3 signaling factor, phosphorylated on serine 727 (Ser<jats:sub>727<\/jats:sub>) in the absence of detectable canonical tyrosine 705 (Tyr<jats:sub>705<\/jats:sub>)-dependent activation <jats:italic>in vivo<\/jats:italic>. The Ser<jats:sub>727<\/jats:sub>-phosphorylated STAT3 molecule (pSTAT3Ser<jats:sub>727<\/jats:sub>) is localized to the mitochondria and associates with complex I of the respiratory chain. This pSer<jats:sub>727<\/jats:sub> modification is further controlled by glutathione-dependent antioxidant pathway(s) that mediate stromal protection of the leukemic B cells and regulate their viability. Importantly, pSTAT3Ser<jats:sub>727<\/jats:sub>, but neither Tyr705-phosphorylated STAT3 nor total STAT3, levels correlate with prolonged <jats:italic>in vivo<\/jats:italic> CLL B cells survival. Furthermore, STAT3 activity contributes to the resistance to apoptosis of CLL, but not normal B cells, <jats:italic>in vitro<\/jats:italic>. These data reveal that mitochondrial (Mt) pSTAT3Ser<jats:sub>727<\/jats:sub> overactivity is part of the antioxidant defense pathway of CLL B cells that regulates their viability. Mt pSTAT3Ser<jats:sub>727<\/jats:sub> appears to be a newly identified cell-protective signal involved in CLL cells survival. Targeting pSTAT3Ser<jats:sub>727<\/jats:sub> could be a promising new therapeutic approach.<\/jats:p>","DOI":"10.1038\/cddis.2014.393","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T13:03:45Z","timestamp":1412859825000},"page":"e1451-e1451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727"],"prefix":"10.1038","volume":"5","author":[{"given":"C","family":"Capron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Jondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Casetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Jalbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Verhoeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Mass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"B\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bourdoncle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Cramer-Bord\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Dusanter-Fourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"BFcddis2014393_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/CCO.0b013e3283589950","volume":"24","author":"JA Burger","year":"2012","unstructured":"Burger JA . Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape. Curr Opin Oncol 2012; 24: 643\u2013649.","journal-title":"Curr Opin Oncol"},{"key":"BFcddis2014393_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M . B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003; 21: 841\u2013894.","journal-title":"Annu Rev Immunol"},{"key":"BFcddis2014393_CR3","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1182\/blood-2009-07-233692","volume":"115","author":"M Buchner","year":"2010","unstructured":"Buchner M, Baer C, Prinz G, Dierks C, Burger M, Zenz T et al. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood 2010; 115: 4497\u20134506.","journal-title":"Blood"},{"key":"BFcddis2014393_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood-2007-04-087882","volume":"111","author":"D de Totero","year":"2008","unstructured":"de Totero D, Meazza R, Capaia M, Fabbi M, Azzarone B, Balleari E et al. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK\/STAT and ERK1\/2 pathways. Blood 2008; 111: 517\u2013524.","journal-title":"Blood"},{"key":"BFcddis2014393_CR5","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1182\/blood-2004-10-4054","volume":"105","author":"KJ Till","year":"2005","unstructured":"Till KJ, Spiller DG, Harris RJ, Chen H, Zuzel M, CLL, Cawley JC . but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium. Blood 2005; 105: 4813\u20134819.","journal-title":"Blood"},{"key":"BFcddis2014393_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ncb2432","volume":"14","author":"W Zhang","year":"2012","unstructured":"Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 2012; 14: 276\u2013286.","journal-title":"Nat Cell Biol"},{"key":"BFcddis2014393_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr . Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3: 651\u2013662.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2014393_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1182\/blood.V99.1.252","volume":"99","author":"M Benekli","year":"2002","unstructured":"Benekli M, Xia Z, Donohue KA, Ford LA, Pixley LA, Baer MR et al. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood 2002; 99: 252\u2013257.","journal-title":"Blood"},{"key":"BFcddis2014393_CR9","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","volume":"19","author":"J Turkson","year":"2000","unstructured":"Turkson J, Jove R . STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000; 19: 6613\u20136626.","journal-title":"Oncogene"},{"key":"BFcddis2014393_CR10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1101\/gad.1553707","volume":"21","author":"J Yang","year":"2007","unstructured":"Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR . Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21: 1396\u20131408.","journal-title":"Genes Dev"},{"key":"BFcddis2014393_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1126\/science.1171721","volume":"324","author":"DJ Gough","year":"2009","unstructured":"Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE . Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009; 324: 1713\u20131716.","journal-title":"Science"},{"key":"BFcddis2014393_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1126\/science.1164551","volume":"323","author":"J Wegrzyn","year":"2009","unstructured":"Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323: 793\u2013797.","journal-title":"Science"},{"key":"BFcddis2014393_CR13","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1172\/JCI119869","volume":"100","author":"DA Frank","year":"1997","unstructured":"Frank DA, Mahajan S, Ritz J . B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest 1997; 100: 3140\u20133148.","journal-title":"J Clin Invest"},{"key":"BFcddis2014393_CR14","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","volume":"115","author":"I Hazan-Halevy","year":"2010","unstructured":"Hazan-Halevy I, Harris D, Liu Z, Liu J, Li P, Chen X et al. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 2010; 115: 2852\u20132863.","journal-title":"Blood"},{"key":"BFcddis2014393_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/cr.2008.41","volume":"18","author":"J Yang","year":"2008","unstructured":"Yang J, Stark GR . Roles of unphosphorylated STATs in signaling. Cell Res 2008; 18: 443\u2013451.","journal-title":"Cell Res"},{"key":"BFcddis2014393_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1172\/JCI6184","volume":"104","author":"V Procaccio","year":"1999","unstructured":"Procaccio V, Mousson B, Beugnot R, Duborjal H, Feillet F, Putet G et al. Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts. J Clin Invest 1999; 104: 83\u201392.","journal-title":"J Clin Invest"},{"key":"BFcddis2014393_CR17","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","volume":"114","author":"AV Kurtova","year":"2009","unstructured":"Kurtova AV, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga MP et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009; 114: 4441\u20134450.","journal-title":"Blood"},{"key":"BFcddis2014393_CR18","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/sj.leu.2403545","volume":"18","author":"JS Carew","year":"2004","unstructured":"Carew JS, Nawrocki ST, Xu RH, Dunner K, McConkey DJ, Wierda WG et al. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia 2004; 18: 1934\u20131940.","journal-title":"Leukemia"},{"key":"BFcddis2014393_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-6143.2006.01577.x","volume":"7","author":"B Armann","year":"2007","unstructured":"Armann B, Hanson MS, Hatch E, Steffen A, Fernandez LA . Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant 2007; 7: 38\u201347.","journal-title":"Am J Transplant"},{"key":"BFcddis2014393_CR20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/carcin\/bgr111","volume":"32","author":"L Mi","year":"2011","unstructured":"Mi L, Di Pasqua AJ, Chung FL . Proteins as binding targets of isothiocyanates in cancer prevention. Carcinogenesis 2011; 32: 1405\u20131413.","journal-title":"Carcinogenesis"},{"key":"BFcddis2014393_CR21","doi-asserted-by":"publisher","first-page":"e83395","DOI":"10.1371\/journal.pone.0083395","volume":"8","author":"DJ Gough","year":"2013","unstructured":"Gough DJ, Koetz L, Levy DE . The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation. PLoS One 2013; 8: e83395.","journal-title":"PLoS One"},{"key":"BFcddis2014393_CR22","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2009-05-220798","volume":"114","author":"C Frecha","year":"2009","unstructured":"Frecha C, Costa C, Levy C, Negre D, Russell SJ, Maisner A et al. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood 2009; 114: 3173\u20133180.","journal-title":"Blood"},{"key":"BFcddis2014393_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/sj.leu.2403667","volume":"19","author":"YK Lee","year":"2005","unstructured":"Lee YK, Shanafelt TD, Bone ND, Strege AK, Jelinek DF, Kay NE . VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia 2005; 19: 513\u2013523.","journal-title":"Leukemia"},{"key":"BFcddis2014393_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nature04940","volume":"442","author":"A Androutsellis-Theotokis","year":"2006","unstructured":"Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006; 442: 823\u2013826.","journal-title":"Nature"},{"key":"BFcddis2014393_CR25","doi-asserted-by":"publisher","first-page":"15636","DOI":"10.1074\/jbc.M601863200","volume":"281","author":"YP Ng","year":"2006","unstructured":"Ng YP, Cheung ZH, Ip NY . STAT3 as a downstream mediator of Trk signaling and functions. J Biol Chem 2006; 281: 15636\u201315644.","journal-title":"J Biol Chem"},{"issue":"Pt 13","key":"BFcddis2014393_CR26","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1242\/jcs.102210","volume":"125","author":"S Ohta","year":"2012","unstructured":"Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H et al. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem\/progenitor cells. J Cell Sci 2012; 125 (Pt 13): 3210\u20133220.","journal-title":"J Cell Sci"},{"key":"BFcddis2014393_CR27","doi-asserted-by":"publisher","first-page":"26765","DOI":"10.1074\/jbc.M109.092304","volume":"285","author":"S Courapied","year":"2010","unstructured":"Courapied S, Sellier H, de Carne Trecesson S, Vigneron A, Bernard AC, Gamelin E et al. The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition. J Biol Chem 2010; 285: 26765\u201326778.","journal-title":"J Biol Chem"},{"key":"BFcddis2014393_CR28","doi-asserted-by":"publisher","first-page":"29610","DOI":"10.1074\/jbc.M111.226209","volume":"286","author":"K Szczepanek","year":"2011","unstructured":"Szczepanek K, Chen Q, Derecka M, Salloum FN, Zhang Q, Szelag M et al. Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem 2011; 286: 29610\u201329620.","journal-title":"J Biol Chem"},{"key":"BFcddis2014393_CR29","doi-asserted-by":"publisher","first-page":"e21680","DOI":"10.1371\/journal.pone.0021680","volume":"6","author":"L Zhou","year":"2011","unstructured":"Zhou L, Too HP . Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS One 2011; 6: e21680.","journal-title":"PLoS One"},{"key":"BFcddis2014393_CR30","doi-asserted-by":"publisher","first-page":"31280","DOI":"10.1074\/jbc.M113.505057","volume":"288","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Raje V, Yakovlev VA, Yacoub A, Szczepanek K, Meier J et al. Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727. J Biol Chem 2013; 288: 31280\u201331288.","journal-title":"J Biol Chem"},{"key":"BFcddis2014393_CR31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0891-5849(01)00521-4","volume":"30","author":"AM Oltra","year":"2001","unstructured":"Oltra AM, Carbonell F, Tormos C, Iradi A, Saez GT . Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic Biol Med 2001; 30: 1286\u20131292.","journal-title":"Free Radic Biol Med"},{"key":"BFcddis2014393_CR32","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1182\/blood-2002-08-2512","volume":"101","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P . Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 2003; 101: 4098\u20134104.","journal-title":"Blood"},{"key":"BFcddis2014393_CR33","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1016\/j.bbagen.2012.10.018","volume":"1830","author":"M Mari","year":"2013","unstructured":"Mari M, Morales A, Colell A, Garcia-Ruiz C, Kaplowitz N, Fernandez-Checa JC . Mitochondrial glutathione: features, regulation and role in disease. Biochim Biophys Acta 2013; 1830: 3317\u20133328.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2014393_CR34","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.4161\/cc.9.21.13677","volume":"9","author":"PE Shaw","year":"2010","unstructured":"Shaw PE . Could STAT3 provide a link between respiration and cell cycle progression? Cell Cycle 2010; 9: 4294\u20134296.","journal-title":"Cell Cycle"},{"key":"BFcddis2014393_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/en.2008-1241","volume":"150","author":"Y Xie","year":"2009","unstructured":"Xie Y, Kole S, Precht P, Pazin MJ, Bernier M . S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology 2009; 150: 1122\u20131131.","journal-title":"Endocrinology"},{"key":"BFcddis2014393_CR36","doi-asserted-by":"publisher","first-page":"23532","DOI":"10.1074\/jbc.C110.152652","volume":"285","author":"D Phillips","year":"2010","unstructured":"Phillips D, Reilley MJ, Aponte AM, Wang G, Boja E, Gucek M et al. Stoichiometry of STAT3 and mitochondrial proteins: Implications for the regulation of oxidative phosphorylation by protein-protein interactions. J Biol Chem 2010; 285: 23532\u201323536.","journal-title":"J Biol Chem"},{"key":"BFcddis2014393_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cyto.a.21061","volume":"79","author":"C Cottet-Rousselle","year":"2011","unstructured":"Cottet-Rousselle C, Ronot X, Leverve X, Mayol JF . Cytometric assessment of mitochondria using fluorescent probes. Cytometry A 2011; 79: 405\u2013425.","journal-title":"Cytometry A"},{"key":"BFcddis2014393_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","volume":"118","author":"JM Irish","year":"2004","unstructured":"Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, Gjertsen BT et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118: 217\u2013228.","journal-title":"Cell"},{"issue":"Pt 3","key":"BFcddis2014393_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordelieres FP . A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224 (Pt 3): 213\u2013232.","journal-title":"J Microsc"},{"key":"BFcddis2014393_CR40","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood.V87.4.1385.bloodjournal8741385","volume":"87","author":"G Berger","year":"1996","unstructured":"Berger G, Masse JM, Cramer EM . Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood 1996; 87: 1385\u20131395.","journal-title":"Blood"},{"key":"BFcddis2014393_CR41","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1128\/MCB.23.24.8934-8945.2003","volume":"23","author":"S Magne","year":"2003","unstructured":"Magne S, Caron S, Charon M, Rouyez MC, STAT5 Dusanter-Fourt I . and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol Cell Biol 2003; 23: 8934\u20138945.","journal-title":"Mol Cell Biol"}],"updated-by":[{"DOI":"10.1038\/cddis.2014.596","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2014393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014393","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:24:19Z","timestamp":1672961059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["BFcddis2014393"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.393","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]},"assertion":[{"value":"15 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2015","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been corrected since Online Publication and a corrigendum has also been published","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}